Aaron Cowen, 10% Owner, Director at Benitec Biopharma Inc. (BNTC), bought 89,610 shares at $11.25 ($994K) on 2024-12-24, disclosed to the SEC on 2024-12-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.98 | 3,142 | $34K | 3.5% |
| 2 | $10.98 | 24,360 | $267K | 26.9% |
| 3 | $10.98 | 24,360 | $267K | 26.9% |
| 4 | $11.25 | 2,288 | $26K | 2.6% |
| 5 | $11.25 | 17,730 | $199K | 20.1% |
| 6 | $11.25 | 17,730 |
| $199K |
| 20.1% |
| Total | $11.09 avg | 89,610 | $994K | 100% |
| Filing → |
| PROK | BUY | 2022-09-08 | $49K | — | Filing → |
| PROK | BUY | 2022-09-01 | $34K | — | Filing → |